Ensysce Biosciences, Inc. (ENSC)
0.4803
+0.01
(+1.54%)
USD |
NASDAQ |
Sep 09, 10:55
Ensysce Biosciences Total Assets (Quarterly) : 2.957M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.957M |
| March 31, 2026 | 2.168M |
| December 31, 2025 | 7.452M |
| September 30, 2025 | 3.180M |
| June 30, 2025 | 5.574M |
| March 31, 2025 | 4.612M |
| December 31, 2024 | 5.597M |
| September 30, 2024 | 9.385M |
| June 30, 2024 | 2.796M |
| March 31, 2024 | 5.074M |
| December 31, 2023 | 2.708M |
| September 30, 2023 | 3.219M |
| June 30, 2023 | 6.358M |
| March 31, 2023 | 3.915M |
| December 31, 2022 | 5.885M |
| September 30, 2022 | 8.290M |
| June 30, 2022 | 7.949M |
| March 31, 2022 | 12.37M |
| Date | Value |
|---|---|
| December 31, 2021 | 16.42M |
| September 30, 2021 | 9.718M |
| June 30, 2021 | 9.196M |
| March 31, 2021 | 12.98M |
| December 31, 2020 | 0.3518M |
| September 30, 2020 | 13.29M |
| June 30, 2020 | 13.41M |
| March 31, 2020 | 61.60M |
| December 31, 2019 | 196.51M |
| September 30, 2019 | 207.21M |
| June 30, 2019 | 206.36M |
| March 31, 2019 | 205.56M |
| December 31, 2018 | 204.83M |
| September 30, 2018 | 204.03M |
| June 30, 2018 | 203.23M |
| March 31, 2018 | 202.87M |
| December 31, 2017 | 202.43M |
| September 30, 2017 | 0.40M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 14.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.068M |
| Shareholders Equity (Quarterly) | -0.7817M |
| Debt to Equity Ratio | -0.2518 |
| Current Ratio | 0.6031 |
| Net Debt Paydown Yield | 0.18% |